Surgery for urinary incontinence in women: Report from the 6th international consultation on incontinence.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
02 2019
Historique:
received: 13 06 2018
accepted: 23 10 2018
pubmed: 5 12 2018
medline: 8 2 2020
entrez: 5 12 2018
Statut: ppublish

Résumé

Urinary incontinence is a prevalent condition worldwide and causes a tremendous impact on a woman's quality of life. While conservative and non-surgical therapies are options for treatment, surgery for stress urinary incontinence (SUI) is common. Options include colposuspension, slings (pubovaginal and midurethral), and periurethral bulking. While evidence supports each of these options in the treatment of SUI, each is associated with various rates of success and unique adverse event profiles. Urgency urinary incontinence (UUI) is initially treated with behavioral modification and pharmacologic means, with surgery reserved for those with refractory symptoms or significant complications from medication use. At present, intravesical onabotulinumtoxinA injections, percutaneous tibial nerve stimulation, and sacral neurostimulation are all viable options for refractory UUI/overactive bladder. As with surgical interventions for SUI, each of these is, likewise, associated with unique outcomes and adverse event profiles. Herein, we summarize the findings and conclusions from the 6th International Consultation on Incontinence (ICI) regarding surgical treatment of urinary incontinence in women.

Identifiants

pubmed: 30512219
doi: 10.1002/nau.23895
doi:

Substances chimiques

Urological Agents 0
Botulinum Toxins, Type A EC 3.4.24.69

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

825-837

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Alex Gomelsky (A)

Department of Urology, Louisiana State University Health Sciences Center, Shreveport, Louisiana.

Stavros Athanasiou (S)

1st Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, "Alexandra" Hospital, Athens, Greece.

Myung-Soo Choo (MS)

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Michel Cosson (M)

Hopital Jeanne de Flandres, Lille Cedex, France.

Roger R Dmochowski (RR)

Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.

Cristiano M Gomes (CM)

Division of Urology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil.

Ash Monga (A)

University Hospital Southampton, Southampton, UK.

Charles W Nager (CW)

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Diego, San Diego, California.

Roy Ng (R)

Division of Urogynaecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynaecology, National University Hospital, Singapore.

Eric S Rovner (ES)

Department of Urology, Medical University of South Carolina, Charleston, South Carolina.

Peter Sand (P)

Division of Urogynecology, NorthShore University Health System, University of Chicago, Pritzker School of Medicine, Skokie, Illinois.

Hikaru Tomoe (H)

Department of Urology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH